Neurogene
NGNE
NGNE
46 hedge funds and large institutions have $306M invested in Neurogene in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% more funds holding
Funds holding: 34 → 46 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
46
Holding in Top 10
2
Calls
$882K
Puts
$255K
Top Buyers
| 1 | +$32.9M | |
| 2 | +$28.1M | |
| 3 | +$5.04M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.52M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$1.87M |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$364K | |
| 3 | -$240K | |
| 4 |
RA
Royce & Associates
New York
|
-$202K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$24.8K |